Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.90
-0.16 (-1.14%)
At close: Mar 23, 2026, 4:00 PM EDT
13.90
0.00 (0.00%)
After-hours: Mar 23, 2026, 5:23 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $845.56 million as of March 23, 2026. Its market cap has decreased by -53.31% in one year.
Market Cap
845.56M
Enterprise Value
-98.87M
1-Year Change
-53.31%
Ranking
Category
Stock Price
$13.90
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $845.56M, an increase of 37.77%. That is a compound annual growth rate of 6.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 845.56M | 1.87% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 891.06M |
| Inhibrx Biosciences | 889.86M |
| Xencor | 889.60M |
| Phathom Pharmaceuticals | 883.33M |
| GH Research | 866.55M |
| SpyGlass Pharma | 866.25M |
| KalVista Pharmaceuticals | 859.29M |
| UroGen Pharma | 857.78M |